APA (7th ed.) Citation

Illidge, T., Bouabdallah, R., Chen, R., Gopal, A. K., Moskowitz, C. H., Ramchandren, R., . . . Advani, R. (2015). Allogeneic transplant following brentuximab vedotin in patients with relapsed or refractory Hodgkin lymphoma and systemic anaplastic large cell lymphoma. Leukemia & Lymphoma, 56(3), 703. https://doi.org/10.3109/10428194.2014.930852

Chicago Style (17th ed.) Citation

Illidge, Tim, et al. "Allogeneic Transplant Following Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma." Leukemia & Lymphoma 56, no. 3 (2015): 703. https://doi.org/10.3109/10428194.2014.930852.

MLA (9th ed.) Citation

Illidge, Tim, et al. "Allogeneic Transplant Following Brentuximab Vedotin in Patients with Relapsed or Refractory Hodgkin Lymphoma and Systemic Anaplastic Large Cell Lymphoma." Leukemia & Lymphoma, vol. 56, no. 3, 2015, p. 703, https://doi.org/10.3109/10428194.2014.930852.